Maximum Approved Dose of Jardiance
The maximum approved dose of Jardiance (empagliflozin) is 25 mg once daily. 1
Dosing Information
According to the FDA drug label, Jardiance is available in two tablet strengths:
- 10 mg tablets
- 25 mg tablets
Both doses are administered once daily and may be taken with or without food 1.
Clinical Context
The 25 mg dose represents the ceiling for therapeutic benefit in clinical practice. In clinical trials, doses up to 100 mg were studied for safety evaluation, but the approved maximum remains 25 mg for all indications 2. The dose-response relationship shows:
- 10 mg dose: Produces urinary glucose excretion of approximately 64 grams per day
- 25 mg dose: Produces urinary glucose excretion of approximately 78 grams per day 1
Both the 10 mg and 25 mg doses demonstrated similar efficacy for glycemic control (approximately 0.8% HbA1c reduction), with the 25 mg dose showing slightly greater effects on weight loss and blood pressure reduction 1, 3.
Special Populations
Heart Failure Patients: While 10 mg is the approved dose for heart failure indications, the 25 mg dose remains the maximum approved dose across all indications. Studies confirm that 10 mg exposure in heart failure patients is still below the 25 mg exposure in type 2 diabetes patients 4.
Renal Impairment: The maximum dose remains 25 mg, though glucose-lowering efficacy diminishes at eGFR <45 mL/min/1.73 m². The drug should be continued for cardiovascular and kidney benefits until dialysis or transplantation 5.
Important Caveat
Do not exceed 25 mg daily—higher doses (such as the 100 mg studied in research) are not approved and provide no additional clinical benefit while potentially increasing adverse effects 2.